Article Versions Notes

Suzuki S, Seino M, Sato H, Saito Y, Saito K, Yamada Y, Takahashi K, Kumanishi R, Fukui T. Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database. Current Issues in Molecular Biology. 2025; 47(6):430. https://doi.org/10.3390/cimb47060430

Suzuki, Shuhei, Manabu Seino, Hidenori Sato, Yosuke Saito, Koki Saito, Yuta Yamada, Koshi Takahashi, Ryosuke Kumanishi, and Tadahisa Fukui. 2025. "Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database" Current Issues in Molecular Biology 47, no. 6: 430. https://doi.org/10.3390/cimb47060430

Suzuki, S., Seino, M., Sato, H., Saito, Y., Saito, K., Yamada, Y., Takahashi, K., Kumanishi, R., & Fukui, T. (2025). Potential Resistance to Oxaliplatin-Based Regimens in Gastric Cancer Patients with ERBB2 R678Q Mutation: Evidence from a National Genomic Database. Current Issues in Molecular Biology, 47(6), 430. https://doi.org/10.3390/cimb47060430